Psychiatric Pharmacy Residency Training

Improving medication-related outcomes for patients with psychiatric and neurologic disorders: Value of psychiatric pharmacists as part of the health care team

“…Pharmacy degrees require the completion of at least 2 years of prerequisite undergraduate science courses and a 4-year professional Doctor of Pharmacy (PharmD) degree program accredited by the American Council on Pharmaceutical Education. 52 In 1997, the bachelor's degree was phased out, and all colleges and schools of pharmacy were required to implement a PharmD program. Students who want to pursue advanced clinical skills training and specialization can complete postgraduate year 1 (PGY-1) residency programs in pharmacy practice and PGY-2 residency programs in specialized clinical areas.…”

“…55 Since 1992, psychiatric pharmacy has been recognized as a specialty by the Board of Pharmacy Specialties (BPS), an independent postlicensure specialty certification agency affiliated with the American Pharmacists Association. 52 Psychiatric pharmacists can be considered board eligible or board certified by the BPS. Pharmacists who earn this certification may use the designation of Board Certified Psychiatric Pharmacist (BCPP).…”

Role of a Psychiatric Pharmacist in a Los Angeles “Skid-Row” safety-net clinic

“…[7][8][9] Patients with severe mental illness have increased mortality rates compared with the general population, which is often the result of health conditions associated with their psychiatric illness, including obesity, metabolic syndrome, and diabetes. 10 A combination of factors such as inadequate access to quality care, poor lifestyle choices, and complex medication regimens with serious potential adverse effects can result in worse outcomes. These patients can benefit from a psychiatric pharmacist's expertise since they are extensively trained in medication therapy management that includes monitoring for adverse drug reactions, interactions, and the need for ongoing medication counseling.…”

“…These patients can benefit from a psychiatric pharmacist's expertise since they are extensively trained in medication therapy management that includes monitoring for adverse drug reactions, interactions, and the need for ongoing medication counseling. 5,[10][11][12] Suboptimal treatment outcomes for depressed primary care patients have been attributed to severe limitation in provider's time, inaccessibility to specialty services, poor medication optimization/adherence, and perceived deficiencies in medical training. [12][13][14] One study in an HMO clinic 14 compared psychiatric pharmacist depression management to "usual care" with a PCP and demonstrated higher 6-month medication adherence rates and decreased resource utilization in the psychiatric pharmacist managed group.…”

Physician–pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients

“…34 In this model, the pharmacist follows up with the patients regarding their substance use since last appointment, adherence with substance abuse treatment programming and self-help group attendance, response to buprenorphine (including craving and with-drawal symptoms), medication adherence and adverse effects, substance use triggers, changes in social issues such as employment and housing, and psychiatric and medical stability. This monitoring is consistent with previous literature.…”